GLANDBSEGland Pharma LtdMediumNeutral
Announced Thu, 14 May · 18:28 IST

Scrutinizers Report on Postal Ballot

Management Changes View source PDF

GLAND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.6%1-day move
₹1895.00
prior close
₹1910.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.5-1.6-0.8+13.6+18.0+16.9+23.4+22.7+21.5+18.5+16.5+30.0
Up moveDown movePending
AI summary

Gland Pharma Limited's shareholders have approved the reappointment of Ms. Naina Lal Kidwai as an Independent Director through a postal ballot voting process. The resolution was passed with overwhelming support, with 94.18% of votes in favor (140.74 million votes) and only 5.82% against (8.70 million votes). The voting participation was strong at 90.70% of total outstanding shares. The reappointment also includes approval for commission on profits as remuneration to her. Ms. Kidwai (DIN: 00017806) will continue serving as an Independent Director on the company's board.

Likely market impact

This is a routine corporate governance matter. The overwhelming approval (94.18%) signals shareholder confidence in Ms. Kidwai's continued stewardship. No material impact on the stock expected, as independent director reappointments are standard board maintenance activities.